Our body has sensors located inside our bodies as well as peripherally in the skin (e.g., receptors, ion channels) that react to mechanical forces. In some cases, these sensors can become oversensitive, causing them to overreact to the slightest force. This is what happens with Restless Leg Syndrome (RLS). Chylobinoid’s effectiveness lies in its ability to calm these sensors down, preventing them from overreacting to even the smallest mechanical force. Here is a white paper detailing our study findings and the accompanying statistical data.
Chylobinoid treatment of RLS, white paper 2024may03IRLSstats
